Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Stone

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Social Psychiatry and Psychiatric Epidemiology|November 8, 2022
Migrant status, clinical symptoms and functional outcome in youth at clinical high risk for psychosis: findings from the NAPLS-3 studyMariapaola Barbato, Lu Liu, Carrie E Bearden, et al.
Psychiatry Research|October 8, 2024
Neighborhood ethnoracial diversity and positive psychotic symptoms among youth at high-risk and healthy comparisonsBenson S Ku, Qingyue Yuan, Regine Haardörfer, et al.
Scientific Reports|June 12, 2023
Genome-wide genetic variation and molecular surveillance of drug resistance in Plasmodium falciparum isolates from asymptomatic individuals in Ouélessébougou, MaliLeen N Vanheer, Almahamoudou Mahamar, Emilia Manko, et al.
Social Psychiatry and Psychiatric Epidemiology|February 3, 2022
Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohortAmy Braun, Lu Liu, Carrie E Bearden, et al.
Journal of Vascular Surgery|December 18, 2020
Telemedicine in vascular surgery during the coronavirus disease-2019 pandemic: A multisite healthcare system experienceYoung Erben, Camila Franco-Mesa, Osman Hamid, et al.
The Lancet. Microbe|January 14, 2022
Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent <i>Plasmodium falciparum</i> malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trialWilliam Stone, Almahamoudou Mahamar, Koualy Sanogo, et al.
Brain, Behavior, and Immunity|January 14, 2024
Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptomsColm Healy, Jonah Byrne, Subash Raj Suasi, et al.
Malaria Journal|April 5, 2025
Preferential transmission of minority and drug-resistant clones in polyclonal infections in MaliLeen N Vanheer, Emilia Manko, Almahamoudou Mahamar, et al.
Frontiers in Psychiatry|May 8, 2023
Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosisCarolyn M Amir, Simon Kapler, Gil D Hoftman, et al.
Schizophrenia Research|November 2, 2020
Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcomeRicardo E Carrión, Andrea M Auther, Danielle McLaughlin, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Social Psychiatry and Psychiatric Epidemiology|November 8, 2022
Migrant status, clinical symptoms and functional outcome in youth at clinical high risk for psychosis: findings from the NAPLS-3 studyMariapaola Barbato, Lu Liu, Carrie E Bearden, et al.
Psychiatry Research|October 8, 2024
Neighborhood ethnoracial diversity and positive psychotic symptoms among youth at high-risk and healthy comparisonsBenson S Ku, Qingyue Yuan, Regine Haardörfer, et al.
Scientific Reports|June 12, 2023
Genome-wide genetic variation and molecular surveillance of drug resistance in Plasmodium falciparum isolates from asymptomatic individuals in Ouélessébougou, MaliLeen N Vanheer, Almahamoudou Mahamar, Emilia Manko, et al.
Social Psychiatry and Psychiatric Epidemiology|February 3, 2022
Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohortAmy Braun, Lu Liu, Carrie E Bearden, et al.
Journal of Vascular Surgery|December 18, 2020
Telemedicine in vascular surgery during the coronavirus disease-2019 pandemic: A multisite healthcare system experienceYoung Erben, Camila Franco-Mesa, Osman Hamid, et al.
The Lancet. Microbe|January 14, 2022
Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent <i>Plasmodium falciparum</i> malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trialWilliam Stone, Almahamoudou Mahamar, Koualy Sanogo, et al.
Brain, Behavior, and Immunity|January 14, 2024
Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptomsColm Healy, Jonah Byrne, Subash Raj Suasi, et al.
Malaria Journal|April 5, 2025
Preferential transmission of minority and drug-resistant clones in polyclonal infections in MaliLeen N Vanheer, Emilia Manko, Almahamoudou Mahamar, et al.
Frontiers in Psychiatry|May 8, 2023
Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosisCarolyn M Amir, Simon Kapler, Gil D Hoftman, et al.
Schizophrenia Research|November 2, 2020
Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcomeRicardo E Carrión, Andrea M Auther, Danielle McLaughlin, et al.
Pageof 9